CompoAtlas

Kori Krill Oil Multi-Benefit Omega-3 800 mg

Kori Krill Oil Multi-Benefit Omega-3 800 mg, NPN 80133668: natural health product licensed in Canada. Medicinal ingredients: Huile de krill.

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Huile de krill

Source : Euphausia superba - en entier

Potency : 96 mg Eicosapentaenoic acid

800 mgNot calculated
Huile de krill

Source : Euphausia superba - en entier

Potency : 44 mg Docosahexaenoic acid

Not specifiedNot calculated

Non-medicinal ingredients

Gélatine, Eau purifiée, Glycérine, Sorbitol

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Source of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health. Helps to reduce pain associated with osteoarthritis. Helps to reduce C-reactive protein levels, a clinical marker of inflammation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Licence holder
Epion Brands LLC.
NPN or DIN-HM
80133668
Status
Active licence
Licence date
21 August 2024
Revision date
Not provided
Form
Capsule, molle
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80133668

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Huile de krill
    Read the warning, when it applies and the studies cited

    Krill Oil

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (HC 2009).

    Sources cited by Health Canada (2)
    • HC 2009: Health Canada, It's your health. Food Allergies. Ottawa (ON): Health Canada. [Original: June 2009; Accessed 2024 November 20]. Available from: https://www.hc-sc.gc.ca/hl-vs/alt_formats/pacrb-dgapcr/pdf/iyh-vsv/food-aliment/allerg-eng.pdf
    • SC 2009: Santé Canada, Votre santé et vous. Allergies alimentaires. Ottawa (ON) : Santé Canada. [Original: Juin 2009; Consulté le 20 novembre 2024] Disponible à : https://www.hc-sc.gc.ca/hl-vs/alt_formats/pacrb-dgapcr/pdf/iyh-vsv/food-aliment/allerg-fra.pdf

    Health Canada monograph dated 25 September 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Kori Krill Oil Multi-Benefit Omega-3 800 mg (Epion Brands LLC.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80133668-kori-krill-oil-multi-benefit-omega-3-800-mg, updated 21 August 2024.

Enter to analyse, Shift+Enter for a new line